Rep. Lisa C. McClain Sells Off Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Representative Lisa C. McClain (R-Michigan) recently sold shares of Option Care Health, Inc. (NASDAQ:OPCH). In a filing disclosed on November 21st, the Representative disclosed that they had sold between $1,001 and $15,000 in Option Care Health stock on October 30th. The trade occurred in the Representative’s “CHARLES SCHWAB BROKERAGE ACCOUNT 924” account.

Representative Lisa C. McClain also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Ciena (NYSE:CIEN) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Coherent (NYSE:COHR) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Clorox (NYSE:CLX) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Northern Trust (NASDAQ:NTRS) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Honda Motor (NYSE:HMC) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Home BancShares (NYSE:HOMB) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Five Below (NASDAQ:FIVE) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of Pure Storage (NYSE:PSTG) on 10/31/2025.
• Sold $1,001 – $15,000 in shares of BHP Group (NYSE:BHP) on 10/31/2025.

Option Care Health Price Performance

NASDAQ OPCH traded down $0.20 during trading hours on Thursday, reaching $31.02. The company’s stock had a trading volume of 1,433,942 shares, compared to its average volume of 1,930,594. Option Care Health, Inc. has a 1 year low of $22.29 and a 1 year high of $35.53. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The company has a market capitalization of $4.92 billion, a price-to-earnings ratio of 24.82, a PEG ratio of 1.74 and a beta of 0.88. The firm’s 50-day moving average price is $27.93 and its 200-day moving average price is $29.43.

Insider Buying and Selling at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the company’s stock in a transaction that occurred on Monday, November 3rd. The stock was purchased at an average cost of $25.98 per share, with a total value of $987,240.00. Following the purchase, the director owned 413,390 shares in the company, valued at approximately $10,739,872.20. This trade represents a 10.12% increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Norman L. Wright purchased 3,411 shares of the business’s stock in a transaction that occurred on Tuesday, September 9th. The shares were purchased at an average price of $29.31 per share, for a total transaction of $99,976.41. Following the completion of the acquisition, the director directly owned 15,501 shares in the company, valued at $454,334.31. The trade was a 28.21% increase in their position. The SEC filing for this purchase provides additional information. 0.64% of the stock is owned by insiders.

Analyst Ratings Changes

Several equities analysts have recently commented on the stock. Morgan Stanley started coverage on shares of Option Care Health in a report on Friday, October 17th. They issued an “overweight” rating and a $35.00 target price on the stock. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a report on Friday, October 31st. Citizens Jmp decreased their price target on shares of Option Care Health from $38.00 to $36.00 and set a “market outperform” rating on the stock in a research note on Friday, October 31st. Barrington Research restated an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a research report on Friday, October 31st. Finally, Wall Street Zen cut Option Care Health from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Nine analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to data from MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and a consensus price target of $35.67.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in OPCH. Teton Advisors Inc. increased its stake in Option Care Health by 2.2% during the second quarter. Teton Advisors Inc. now owns 17,368 shares of the company’s stock worth $564,000 after acquiring an additional 368 shares during the last quarter. US Bancorp DE boosted its holdings in shares of Option Care Health by 5.0% in the 1st quarter. US Bancorp DE now owns 8,199 shares of the company’s stock worth $287,000 after purchasing an additional 393 shares during the period. Assetmark Inc. increased its position in shares of Option Care Health by 1.6% during the 2nd quarter. Assetmark Inc. now owns 26,690 shares of the company’s stock valued at $867,000 after purchasing an additional 416 shares during the last quarter. State of Wyoming raised its holdings in Option Care Health by 1.8% during the 2nd quarter. State of Wyoming now owns 25,135 shares of the company’s stock valued at $816,000 after buying an additional 436 shares during the period. Finally, Sheets Smith Wealth Management raised its holdings in Option Care Health by 1.9% during the 2nd quarter. Sheets Smith Wealth Management now owns 24,938 shares of the company’s stock valued at $810,000 after buying an additional 457 shares during the period. Institutional investors own 98.05% of the company’s stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan’s 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan’s 9th Congressional District. She declared candidacy for the 2026 election.

Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor’s degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.